The conundrum of hyperuricemia, metabolic syndrome, and renal disease

Internal and Emergency Medicine

Volumn 3, Issue 4, 2008, Pages 313-318

  Nakagawa, Takahiko ^a   Cirillo, Pietro ^a   Sato, Waichi ^a   Gersch, Michael ^a   Sautin, Yuri ^a   Roncal, Carlos ^a   Mu, Wei ^a   Sánchez Lozada, L Gabriela ^b   Johnson, Richard J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Insulin resistance; Metabolic syndrome; Renal disease; Uric acid

Indexed keywords

URIC ACID;

ANIMAL; BLOOD; HUMAN; HYPERTENSION; HYPERURICEMIA; INSULIN RESISTANCE; KIDNEY; KIDNEY FAILURE; METABOLIC SYNDROME X; METABOLISM; REVIEW;

ANIMALS; HUMANS; HYPERTENSION; HYPERURICEMIA; INSULIN RESISTANCE; KIDNEY; KIDNEY FAILURE; METABOLIC SYNDROME X; URIC ACID;

EID: 55949093135     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-008-0141-3     Document Type: Review

References (50)

1. AM Fishberg 1924 The interpretation of increased blood uric acid in hyertension Arch Int Med 34 503 507
2. AP Hall PE Barry TR Dawber 1967 Epidemiology of gout and hyperuricemia. A long-term population study Am J Med 42 27 37
3. RJ Glynn EW Campion JE Silbert 1983 Trends in serum uric acid levels 1961-1980 Arthritis Rheum 26 87 93
4. A Enomoto H Kimura A Chairoungdua 2002 Molecular identification of a renal urate anion exchanger that regulates blood urate levels Nature 417 447 452
5. CA Polkowski SM Grassl 1993 Uric acid transport in rat renal basolateral membrane vesicles Biochim Biophys Acta 1146 145 152
6. RA Van Aubel PH Smeets JJ van den Heuvel 2005 Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites Am J Physiol Renal Physiol 288 F327 F333
7. H Duncan AS Dixon 1960 Gout, familial hypericaemia, and renal disease Q J Med 29 127 135
8. JH Talbott KL Terplan 1960 The kidney in gout Medicine (Baltimore) 39 405 467
9. JW Linnane AF Burry BT Emmerson 1981 Urate deposits in the renal medulla. Prevalence and associations Nephron 29 216 222
10. LG Hunsicker S Adler A Caggiula 1997 Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study Kidney Int 51 1908 1919
11. M Tomita S Mizuno H Yamanaka 2000 Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers J Epidemiol 10 403 409
12. K Iseki S Oshiro M Tozawa 2001 Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects Hypertens Res 24 691 697
13. I Ohno T Hosoya H Gomi 2001 Serum uric acid and renal prognosis in patients with IgA nephropathy Nephron 87 333 339
14. CH Tseng 2005 Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan Kidney Int 68 796 801
15. Y Siu K Leung M Tong 2006 Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level Am J Kidney Dis 47 51 59
16. KM Talaat AR El-Sheikh 2007 The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease Am J Nephrol 27 435 440
17. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive, lipid-lowering treatment to prevent heart attack trial (ALLHAT). Jama 2002; 288:2981-2997
18. F Turnbull 2003 Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials Lancet 362 1527 1535
19. A Fletcher A Amery W Birkenhager 1991 Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly J Hypertens 9 225 230
20. PJ Savage SL Pressel JD Curb 1998 Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the systolic hypertension in the Elderly Program. SHEP Cooperative Research Group Arch Intern Med 158 741 751
21. MJ Brown CR Palmer A Castaigne 2000 Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) Lancet 356 366 372
22. LV Franse M Pahor M Di Bari 2000 Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP) J Hypertens 18 1149 1154
23. DI Feig RJ Johnson 2003 Hyperuricemia in childhood primary hypertension Hypertension 42 247 252
24. C Zoccali R Maio F Mallamaci 2006 Uric acid and endothelial dysfunction in essential hypertension J Am Soc Nephrol 17 1466 1471
25. W Doehner N Schoene M Rauchhaus 2002 Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies Circulation 105 2619 2624
26. J George E Carr J Davies 2006 High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid Circulation 114 2508 2516
27. ES Ford WH Giles AH Mokdad 2004 Increasing prevalence of the metabolic syndrome among U.S. adults Diabetes Care 27 2444 2449
28. F Facchini YD Chen CB Hollenbeck 1991 Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration Jama 266 3008 3011
29. J Chen P Muntner LL Hamm 2004 The metabolic syndrome and chronic kidney disease in U.S. adults Ann Intern Med 140 167 174
30. S Kobayashi K Maesato H Moriya 2005 Insulin resistance in patients with chronic kidney disease Am J Kidney Dis 45 275 280
31. B Becker F Kronenberg JT Kielstein 2005 Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study J Am Soc Nephrol 16 1091 1098
32. A Quinones Galvan A Natali S Baldi 1995 Effect of insulin on uric acid excretion in humans Am J Physiol 268 E1 E5
33. E Muscelli A Natali S Bianchi 1996 Effect of insulin on renal sodium and uric acid handling in essential hypertension Am J Hypertens 9 746 752
34. T Nakagawa KR Tuttle RA Short 2005 Hypothesis:fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome Nat Clin Pract Nephorl 1 80 86
35. M Mazzali J Hughes YG Kim 2001 Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism Hypertension 38 1101 1106
36. T Nakagawa M Mazzali DH Kang 2003 Hyperuricemia causes glomerular hypertrophy in the rat Am J Nephrol 23 2 7
37. LG Sanchez-Lozada E Tapia J Santamaria 2005 Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats Kidney Int 67 237 247
38. M Mazzali J Kanellis L Han 2002 Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism Am J Physiol Renal Physiol 282 F991 F997
39. DH Kang T Nakagawa L Feng 2002 A role for uric acid in the progression of renal disease J Am Soc Nephrol 13 2888 2897
40. M Mazzali YG Kim S Suga 2001 Hyperuricemia exacerbates chronic cyclosporine nephropathy Transplantation 71 900 905
41. EL Kanabrocki JL Third MD Ryan 2000 Circadian relationship of serum uric acid and nitric oxide Jama 283 2240 2241
42. DI Feig T Nakagawa SA Karumanchi 2004 Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension Kidney Int 66 281 287
43. YY Sautin T Nakagawa S Zharikov 2007 Adverse effects of the classical antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/ nitrosative stress Am J Physiol Cell Physiol 293 C584 C596
44. WS Waring JA McKnight DJ Webb 2006 Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers Diabetes 55 3127 3132
45. WS Waring DJ Webb SR Maxwell 2001 Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers J Cardiovasc Pharmacol 38 365 371
46. M Whiteman B Halliwell 1996 Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants Free Radic Res 25 275 283
47. KA Skinner CR White R Patel 1998 Nitrosation of uric acid by peroxynitrite. Formation of a vasoactive nitric oxide donor J Biol Chem 273 24491 24497
48. I Saito T Saruta K Kondo 1978 Serum uric acid and the renin-angiotensin system in hypertension J Am Geriatr Soc 26 241 247
49. CA Roncal W Mu B Croker 2007 Effect of elevated serum uric acid on cisplatin-induced acute renal failure Am J Physiol Renal Physiol 292 F116 122
50. LG Sanchez-Lozada E Tapia A Jimenez 2006 Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 292 1 F423 F429